Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity

Antimicrob Agents Chemother. 1992 Nov;36(11):2556-8. doi: 10.1128/AAC.36.11.2556.

Abstract

It is known that daily polyaspartic acid (PAA) protects the kidney from gentamicin nephrotoxicity in a standardized rat model despite marked cortical accumulation of the aminoglycoside. The present experiments address the duration of PAA protection. When administered every other day, PAA provided functional and histologic protection against gentamicin-induced toxicity. A stepwise reduction in nephroprotection occurred as the dosage interval was prolonged.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Creatinine / blood
  • Drug Administration Schedule
  • Gentamicins / toxicity*
  • Kidney Diseases / chemically induced
  • Kidney Diseases / prevention & control*
  • Male
  • Nephrons / drug effects*
  • Peptides / pharmacokinetics
  • Peptides / therapeutic use*
  • Rats
  • Rats, Inbred F344
  • Time Factors

Substances

  • Gentamicins
  • Peptides
  • polyaspartate
  • Creatinine